Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Daratumumab-containing regimens safe, effective against multiple myeloma
Adding daratumumab to backbone treatments against multiple myeloma (MM) yields high clinical efficacy and has an acceptable toxicity profile, a recent study has found. Such regimens are good treatment options for newly diagnosed (ND) and relapsed/refractory (RR) MM.
Daratumumab-containing regimens safe, effective against multiple myeloma
21 Nov 2021
MRI/ultrasound fusion biopsy accurately detects PCa in men with intermediate PSA
Fusion biopsy with magnetic resonance imaging and ultrasonography (MRI/US) is an efficient method of detecting clinically significant prostate cancer (csPCa) in biopsy-naïve men with prostate specific antigen (PSA) levels 4–10 ng/mL, a new study has found.
MRI/ultrasound fusion biopsy accurately detects PCa in men with intermediate PSA
19 Nov 2021
Statins reduce hepatocellular carcinoma risk in cirrhotic patients
The risk of hepatocellular carcinoma (HCC) among patients with nonalcoholic steatohepatitis (NASH) and bridging fibrosis is low, reveals a recent study. In addition, dose-dependent statin can substantially lower the risk of HCC in patients with NASH cirrhosis.
Statins reduce hepatocellular carcinoma risk in cirrhotic patients
17 Nov 2021
Low carbohydrate diet lowers risk of MetS, remnant cholesterol in prostate cancer
A low carbohydrate diet (LCD) may substantially reduce the risk of metabolic syndrome (MetS) and remnant cholesterol in patients with prostate cancer, a recent study has shown.
